Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

ARCHER AVIATION INC. (ACHR)

  • SEC News
  • Aug. 20, 2026, 17:04 UTC
  • 1
  • 1 comments

📋 Lentell Eric (Officer) plans to sell 100K shares of Archer Aviation Inc. (at $6.31 each, total $631K) Filed: Aug 20, 2026 | ID: 006258

Comment Full text

TREDEGAR CORP (TG)

  • SEC News
  • Aug. 20, 2026, 17:03 UTC
  • 1
  • 0 comments

New Form SCHEDULE 13D/A - TREDEGAR CORP <b>Filed:</b> 2026-08-20 <b>AccNo:</b> 0001193125-26-359168 <b>Size:</b> 216 KB

Comment Full text

UWM HOLDINGS CORP (UWMC)

  • Business News
  • Aug. 20, 2026, 17:03 UTC
  • 1
  • 1 comments

SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of October 13, 2026 in UWM Holdings Corporation Lawsuit - UWMC

Market reaction Comment Full text

PARK HA BIOLOGICAL TECHNOLOGY CO., LTD. (BYAH)

  • Business News
  • Aug. 20, 2026, 17:03 UTC
  • 0
  • 1 comments

BYAH Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Park Ha Biological Technology Co. Securities Lawsuit - Contact SueWallSt

Market reaction Comment Full text

ALIBABA GROUP HOLDING LTD (BABA)

  • Business News
  • Aug. 20, 2026, 17:03 UTC
  • 1
  • 1 comments

BABA Deadline Alert: SueWallSt Reminds Alibaba Group Holding Limited (BABA) Investors of Securities Class Action Deadline on October 5, 2026

Market reaction Comment Full text

HDFC BANK LTD (HDB)

  • Business News
  • Aug. 20, 2026, 17:03 UTC
  • 1
  • 1 comments

SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of October 13, 2026 in HDFC Bank Limited Lawsuit - HDB

Market reaction Comment Full text

EYEPOINT, INC. (EYPT)

  • Business News
  • Aug. 20, 2026, 17:03 UTC
  • 7
  • 1 comments

EYPT SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving EyePoint Pharmaceuticals

Market reaction Comment Full text

REPLIMUNE GROUP, INC. (REPL)

  • Business News
  • Aug. 20, 2026, 17:03 UTC
  • 1
  • 1 comments

REPL UPCOMING DEADLINE: SueWallSt Alerts Replimune Group, Inc. Stockholders of Securities Class Action - Contact the Firm

Market reaction Comment Full text

INSULET CORP (PODD)

  • Business News
  • Aug. 20, 2026, 17:03 UTC
  • 1
  • 1 comments

Lost Money on Insulet Corporation (PODD)? A Class Action Suit is Seeking Recovery - Contact SueWallSt

Market reaction Comment Full text

BLOOM ENERGY CORP (BE)

  • Business News
  • Aug. 20, 2026, 17:03 UTC
  • 1
  • 1 comments

SueWallSt Reminds Bloom Energy Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 28, 2026 - BE

Market reaction Comment Full text

RACKSPACE TECHNOLOGY, INC. (RXT)

  • Business News
  • Aug. 20, 2026, 17:03 UTC
  • 6
  • 1 comments

RXT Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Rackspace Technology Securities Lawsuit - Contact SueWallSt

Market reaction Comment Full text

PENTAIR PLC (PNR)

  • Business News
  • Aug. 20, 2026, 17:03 UTC
  • 1
  • 1 comments

PNR Investor Alert: Pentair plc Securities Class Action Notice - Contact SueWallSt

Market reaction Comment Full text

CAPRICOR THERAPEUTICS, INC. (CAPR)

  • Business News
  • Aug. 20, 2026, 17:03 UTC
  • 1
  • 1 comments

CAPR Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Capricor Therapeutics Securities Lawsuit - Contact SueWallSt

Market reaction Comment Full text

ARS PHARMACEUTICALS, INC. (SPRY)

  • Business News
  • Aug. 20, 2026, 17:03 UTC
  • 1
  • 1 comments

SPRY Investor Alert: ARS Pharmaceuticals Inc. Securities Class Action Notice - Contact SueWallSt

Market reaction Comment Full text

WISE GROUP PLC (WSE)

  • Business News
  • Aug. 20, 2026, 17:03 UTC
  • 1
  • 1 comments

SueWallSt Reminds Wise Group plc Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 29, 2026 - WSE

Market reaction Comment Full text
  • Previous
  • 1067
  • 1068
  • 1069
  • 1070
  • 1071
  • Next

Search

News categories

  • Technical Exchange News(14624)
  • Event(6229)
  • SEC News(386645)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(236027)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin